Headlands Technologies LLC Regenxbio Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$11.51 - $21.53 $33,390 - $62,458	-2,901 Reduced 75.78%	927 $10,000
Q1 2024 May 07, 2024	BUY	$12.17 - $24.61 $34,222 - $69,203	2,812 Added 276.77%	3,828 $80,000
Q4 2023 Feb 02, 2024	BUY	$12.89 - $20.82 $13,096 - $21,153	1,016 New	1,016 $18,000
Q2 2023 Aug 03, 2023	BUY	$17.23 - $21.71 $37,974 - $47,848	2,204 New	2,204 $44,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.